Home › NDC Lookup › RxCUI directory › RxCUI 1303125

Prednisone 1 MG Delayed Release Oral Tablet — RxCUI 1303125

RxNorm drug concept · Semantic clinical drug
RxCUI 1303125 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 6 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1303125
Official namePrednisone 1 MG Delayed Release Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped4
Package NDCs mapped6
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Prednisone: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Prednisone calms down your immune system and reduces inflammation in your body. It's used for a huge range of conditions — everything from asthma and severe allergies to Crohn's di...
  • Why did my doctor put me on prednisone — what does it actually do?
  • Yes, morning really does matter — your body naturally produces its own cortisol hormone between 2 a.m. and 8 a.m., and taking prednisone at that time works with your body's rhythm...
  • Do I really have to take it in the morning? And does it matter if I take it with food?
📖 Read our full Prednisone guide →

🕸️ Concept Web — How Prednisone 1 MG Delayed Release Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Prednisone 1 MG Delayed Release Oral Tablet RxCUI 1303125

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Prednisone 8640
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Rayos 1303126
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Prednisone Delayed Release Oral Tablet 1303124
    • Prednisone Oral Product 1161705
    • Prednisone Pill 1161706
    • Prednisone Delayed Release Oral Tablet [Rayos] 1303128
    • Rayos Oral Product 1303129
    • Rayos Pill 1303130
    • Delayed Release Oral Tablet 10312
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Prednisone 1 MG 317475
    • Prednisone 1 MG Delayed Release Oral Tablet [Rayos] 1303131
    • Prednisone 1 MG [Rayos] 1303127

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Prednisone 1 MG SCDC · 317475
  • Prednisone Delayed Release Oral Tablet SCDF · 1303124
  • Prednisone Oral Product SCDG · 1161705
  • Prednisone Pill SCDG · 1161706

Brand-Name Concepts

  • Prednisone 1 MG Delayed Release Oral Tablet [Rayos] SBD · 1303131
  • Prednisone 1 MG [Rayos] SBDC · 1303127
  • Prednisone Delayed Release Oral Tablet [Rayos] SBDF · 1303128
  • Rayos Oral Product SBDG · 1303129
  • Rayos Pill SBDG · 1303130
  • Rayos BN · 1303126

📦 FDA Products & Package NDCs

4 products · 6 package NDCs
6 package NDCs map to RxCUI 1303125 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
43598-0886-01 1 BOTTLE in 1 CARTON (43598-886-01) / 100 TABLET, DELAYED R... Prednisone delayed release Dr. Reddys Laboratories Inc. 2025-12-15
43598-0886-30 1 BOTTLE in 1 CARTON (43598-886-30) / 30 TABLET, DELAYED RE... Prednisone delayed release Dr. Reddys Laboratories Inc. 2025-12-15
43598-0887-01 1 BOTTLE in 1 CARTON (43598-887-01) / 100 TABLET, DELAYED R... Prednisone delayed release Dr. Reddys Laboratories Inc. 2025-12-15
43598-0887-30 1 BOTTLE in 1 CARTON (43598-887-30) / 30 TABLET, DELAYED RE... Prednisone delayed release Dr. Reddys Laboratories Inc. 2025-12-15
74157-0010-30 1 BOTTLE in 1 CARTON (74157-010-30) / 30 TABLET, DELAYED RE... Prednisone delayed release INA Pharmaceutics Inc 2025-12-15
74157-0019-30 1 BOTTLE in 1 CARTON (74157-019-30) / 30 TABLET, DELAYED RE... Prednisone delayed release INA Pharmaceutics Inc 2025-12-15
Observed labelers: Dr. Reddys Laboratories Inc. (4) · INA Pharmaceutics Inc (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.